Publication
Oral BG-12 (dimethyl fumarate) for relapsing–remitting multiple sclerosis: a review of DEFINE and CONFIRM
Evaluation of: Gold R, Kappos L, Arnold D,et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;367:1098-107; and Fox RJ, Miller DH, Phillips JT,et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 2012;367:1087-97
Eva Havrdova, Michael Hutchinson, Nuwan C Kurukulasuriya, Kartik Raghupathi, Marianne T Sweetser, Katherine T Dawson, Ralf Gold
Expert Opinion on Pharmacotherapy, August 2013, Informa Healthcare
DOI: 10.1517/14656566.2013.826190